Cellular growth factors in relation to mortality from cardiovascular disease in middle-aged Japanese: The JACC study

Atherosclerosis

Volumn 224, Issue 1, 2012, Pages 154-160

  Iso, Hiroyasu ^a   Maruyama, Koutatsu ^a,b   Ikehara, Satoyo ^a   Yamagishi, Kazumasa ^c   Tamakoshi, Akiko ^d,e  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarkers; Coronary heart disease; Mortality; Nested case control study; Stroke

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CASE CONTROL STUDY; CELL PROLIFERATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION STRUCTURE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK; STROKE; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; JAPAN; MALE; MIDDLE AGED; STROKE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84865351121     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.05.026     Document Type: Article

References (30)

1. Lusis A.J. Atherosclerosis Nat 2000, 407:233-241.
2. Lammie G.A. Pathology of small vessel stroke. Brit Med Bull 2000, 56:296-306.
3. Bayes-Genis A., Conover C.A., Schwartz R.S. The insulin-like growth factor axis. A review of atherosclerosis and restenosis. Cir Res 2000, 86:125-130.
4. Okura Y., Brink M., Zahid A.A., Anwar A., Delafontaine P. Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol 2001, 33:1777-1789.
5. Blobe G.C., Schiemann W.P., Lodish H.F. Role of transforming growth factor β in human disease. N Engl J Med 2000, 342:1350-1358.
6. Bobik A. Transforming growth factor-βs and vascular disorders. Arterioscler Thromb Vasc Biol 2006, 26:1712-1720.
7. Fischer F., Schulte H., Mohan S., et al. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Clin Endocrinol (Oxf) 2004, 61595-61602.
8. Kawachi S., Takeda N., Sasaki A., et al. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2005, 25:617-621.
9. Spallarossa P., Brunelli C., Minuto F., et al. Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol 1996, 77:200-202.
10. Goodman-Gruen D., Barnett-Connor E., Rosen C. IGF-I and ischemic heart disease in older people. J Am Geriatr Soc 2000, 48:860-861.
11. Juul A., Scheike T., Davidsen M., Gyllenborg J., Jørgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002, 20(106):939-944.
12. Laughlin G.A., Barrett-Connor E., Criqui M.H., Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo study. J Clin Endocrinol Metab 2004, 89:114-120.
13. Denti L., Annoni V., Cattadori E., et al. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 2004, 1(117):312-317.
14. Johnsen S.P., Hundborg H.H., Sørensen H.T., et al. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 2005, 90:5937-5941.
15. Kaplan R.C., McGinn A.P., Pollak M.N., et al. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 2007, 92:1319-1325.
16. Andreassen M., Raymond I., Kistorp C., Hildebrandt P., Faber J., Kristensen L. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur J Endocrinol 2009, 160:25-31.
17. Schuler-Luttmann S., Monning G., Enbergs A., et al. Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis. Arterioscler Thromb Vasc Biol 2000, 20:e10-e15.
18. Stefoni S., Cianciolo G., Donati G., et al. Low TGF-β1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int 2002, 61:324-335.
19. Tashiro H., Shimokawa H., Sadamatu K., Yamamoto K. Prognostic significance of plasma concentrations of transforming factor-β in patients with coronary heart disease. Coron Artery Dis 2002, 13:139-143.
20. Ohno Y., Tamakoshi A., the JACC Study Group Japan collaborative cohort study for evaluation of cancer risk sponsored by Monbusho (JACC study). J Epidemiol 2001, 11:144-150.
21. Ito Y., Nakachi K., Imai K., et al. Stability of frozen serum levels of insulin-like growth factor-1, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. J Epidemiol 2005, 15(Suppl. 1):S67-S73.
22. Nakamura M., Sato S., Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US cholesterol reference method laboratory network. J Atheroscler Thromb 2003, 10:145-153.
23. Colao A., Di Somma C., Cascella T., et al. Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol 2008, 159:389-397.
24. Iso H., Imano H., Kitamura A., et al. Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women. Diabetologia 2004, 47:2137-2144.
25. Iso H., Jacobs D.R., Wentworth D., Neaton J.D., Cohen J.D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989, 320:904-910.
26. Martin R.M., Gunnell D., Whitley E., et al. Associations of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (IGFBP)-2 and IGFBP-3 with ultrasound measures of atherosclerosis and plaque stability in an older adult population. J Clin Endocrinol Metab 2008, 93:1331-1338.
27. Cipollone F., Fazia M., Mincione G., et al. Increased expression of transforming growth factor-β1 in human atherosclerotic plaques. Stroke 2004, 35:2253-2257.
28. Frystyk J. Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 2004, 14:337-375.
29. Sasamamoto T., Iida M., Tanigaki M., et al. A population-based study of the proportion by type of stroke determined by computed tomography scan. Nippon Koshu Eisei Zasshi 1991, 38:901-909. [in Japanese].
30. Yamashita T., Ozawa H., Aono H., Hosokawa H., Saito I., Ikebe T. Heart disease deaths on death certificates re-evaluated by clinical records in a Japanese city. CHD diagnosis. Jpn Circ J 1997, 61:331-338.